SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject10/20/2001 8:03:31 PM
From: scaram(o)uche  Read Replies (2) of 724
 
DGI/Novo patent application.......

INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS

Patent Number:
WO0172771
Publication date:
2001-10-04
Inventor(s):
MANDECKI WLODEK S; BEASLEY JAMES; CHENG WEIQING; RAVERA MARK; SPETZLER
JANE; BLUME ARTHUR J; BRANDT JAKOB; BRISSETTE RENEE; HSIAO KU-CHUAN; PILLUTLA
RENUKA; SCHAEFFER LAUGE; HANSEN PER HERTZ; OESTERGAARD SOEREN
Applicant(s)::
NOVO NORDISK AS (DK); DGI BIOTECHNOLOGIES L L C
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News